Synopsis: A specialty marine chemicals maker with decades of experience in bromine and industrial salt is now stepping into an entirely new arena. Its bet on Silicon Carbide semiconductors could reshape how investors view this small-cap in the years ahead.
For years, this company built its identity around extracting value from Gujarat’s brine reserves, turning bromine and industrial salt into a steady export business. That business still runs well. But the company has now placed a much bigger bet, one that has nothing to do with brine at all: manufacturing semiconductors. Here’s how the story is unfolding.
With a market capitalization of around Rs. 6,836 crore, shares of Archean Chemical Industries were trading near Rs. 554 apiece, within a 52-week range of Rs. 727.6 to Rs. 483, at a P/E of roughly 66x.
Betting Big on India’s Semiconductor Mission
Archean is no longer just a specialty chemicals company. Through its subsidiary SiCSem, it is setting up India’s first commercial Silicon Carbide (SiC) compound semiconductor fab, backed by the government’s India Semiconductor Mission. On May 11, 2026, SiCSem executed the Fiscal Support Agreement with the mission, an important procedural step toward unlocking the scheme’s incentives. The facility, coming up at Info Valley in Bhubaneswar, Odisha, will manufacture SiC MOSFETs and power devices, placing the company inside one of India’s most strategically watched manufacturing sectors.
Exposure to High-Growth Industries Worth Trillions
Unlike conventional silicon chips, SiC-based devices are gaining traction because of their efficiency advantages, handling higher voltages and temperatures while losing less energy in the process. This makes them especially valuable in applications where power efficiency directly affects performance and cost.
Demand is building across EVs, defence equipment, railway electrification, fast chargers, solar power inverters, consumer appliances, and data centres. If adoption accelerates the way the industry expects, Archean stands to benefit from several structural growth themes at once rather than depending on a single end market for its future revenue.
Massive Manufacturing Capacity Creates Long-Term Opportunity
The upcoming facility is being built with an annual capacity of 60,000 wafers and 96 million packaged units, positioning it as the country’s first commercial compound semiconductor fab.
That scale could help Archean establish itself early as a domestic Silicon Carbide manufacturer just as import substitution in electronics and power devices gathers pace. The company has also taken a 22.24% stake in UK-based Clas-SiC Wafer Fab, giving it access to established SiC process technology, and a stake in US-based Offgrid Energy Labs to build synergies with zinc-bromide battery chemistry.
Strong Chemicals Business Provides the Financial Backbone
While the semiconductor business is still being built out, Archean’s core operations continue to hold up. For FY26, consolidated total income came in at ₹1,174 crore, up 8% year-on-year, though revenue from operations grew a more modest 3% to ₹1,108 crore, weighed down by a soft fourth quarter. Exports contributed nearly 78% of operating revenue, though geopolitical disruptions pushed up transit times and freight costs during the year.
The Industrial Salt segment remained the anchor, growing 10% to ₹729 crore on volumes of 4.25 million tonnes. Bromine, by contrast, declined 13% to ₹308 crore after technical downtime hurt production, though the company says corrective steps are already improving throughput. Consolidated EBITDA fell 24% to ₹266 crore, while profit after tax (PAT) dropped to ₹105.4 crore from ₹162 crore a year earlier, reflecting weakness in the Bromine segment, rising finance costs, and gestation losses in newly acquired subsidiaries
Diversification Beyond Bromine Reduces Business Cyclicality
Apart from semiconductors, Archean is expanding into bromine derivatives through its Acume Chemicals unit, which makes brominated catalysts, clear brine fluids, and flame-retardant compounds, alongside a drilling chemicals business under Idealis Mudchemie.
These businesses are still finding their feet: Acume posted a loss for the year while running at 30-35% utilisation, and Idealis is only now commissioning plants after acquiring the business out of an NCLT liquidation process. Neither is profitable yet, but together they widen Archean’s base beyond its traditional two products.
Can Semiconductors Become the Company’s Biggest Value Creator?
Archean has spent over two decades building a name in specialty marine chemicals, and that business still funds the balance sheet today. But the market’s attention is shifting toward what comes next.
With government-backed fiscal support secured, India’s first commercial SiC compound fab under construction, 60,000-wafer annual capacity in the pipeline, and exposure to sectors from EVs to defence to data centres, the coming few years will determine whether the semiconductor business can emerge as a meaningful new growth driver alongside Archean’s established specialty chemicals operations.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
